Document is current
Any future updates will be listed below
-
Authors
Gunter, Katarina M.
Groenewald, Karolien
Aubourg, Timothee
Lo, Christine
Welch, Jessica
Razzaque, Jamil
van Hillegondsberg, Ludo
Nastasa, Adriana
Ratti, Pietro-Luca
Orso, Beatrice
Mattioli, Pietro
Pardini, Matteo
Raffa, Stefano
Massa, Federico
McGowan, Daniel R.
Bradley, Kevin M.
Arnaldi, Dario
Klein, Johannes C.
Arora, Siddharth
Hu, Michele T.
-
Funding
Funding for this research was provided by:
Oxford Biomedical Research Centre
Parkinson’s UK
Cure Parkinson’s Trust
- License Information
-
More Information
Article History
Received: 13 May 2025
Accepted: 2 November 2025
First Online: 1 December 2025
Competing interests
: Michele Hu and Siddharth Arora report they are advisory founders and shareholders of NeuHealth Digital Ltd (company number: 14492037), a digital biomarker platform to remotely manage condition progression for Parkinson’s. Christine Lo has received royalties from NeuHealth Digital Ltd. Michele Hu currently receives payment for Advisory Board attendance/consultancy from Helicon, NeuHealth Digital, Roche and Manus Neurodynamica. All other authors declare no competing interests.
